Laine Way
Family Medicine · Manning, SCNPI 1114487519
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,228, more than ten times the $15 reported in 2019.
Across 146 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$570
- Novo Nordisk$517
- Amgen$400
- Novartis$302
- GSK$229
- Lilly USA, LLC$222
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $570 |
| Novo Nordisk | 28 | $517 |
| Amgen | 15 | $400 |
| Novartis | 18 | $302 |
| GSK | 3 | $229 |
| Lilly USA, LLC | 16 | $222 |
| AbbVie | 11 | $207 |
| Stryker | 1 | $149 |
| Boehringer Ingelheim | 6 | $133 |
| Dexcom, Inc. | 4 | $127 |
| Phathom Pharmaceuticals, Inc. | 4 | $124 |
| Astellas Pharma US Inc | 2 | $48 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Pfizer | 2 | $35 |
| Exact Sciences | 2 | $34 |
| Edwards Lifesciences | 1 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Smith+Nephew | 1 | $25 |
| Bayer | 2 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Abbott | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$149
- CT THROMBECTOMY SYSTEM KIT$149
- AIRSUPRA$125
- BREZTRI$125
- FARXIGA$125
- SHINGRIX$115
How this compares
$3,348 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 44 | $53,191 |
| MounjaroTirzepatide | 34 | $34,741 |
| EliquisApixaban | 20 | $28,632 |
| OzempicSemaglutide | 20 | $21,047 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $16,883 |
| JanuviaSitagliptin Phosphate | 15 | $16,279 |
| FarxigaDapagliflozin Propanediol | 12 | $15,667 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 15 | $14,195 |
| MyrbetriqMirabegron | 19 | $13,154 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $8,362 |
| Repatha SureclickEvolocumab | 12 | $5,692 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $4,472 |
| Gabapentin | 119 | $2,277 |
| Atorvastatin Calcium | 186 | $1,953 |
| Novolog FlexpenInsulin Aspart | 13 | $1,707 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr | $133 | $67,38659 claims |
| Lilly USA, LLCMounjaro | $222 | $34,74134 claims |
| PfizerEliquis | $35 | $28,63220 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $229 | $21,35438 claims |
| Novo NordiskOzempic | $517 | $21,04720 claims |
| AstraZenecaFarxiga | $570 | $15,66712 claims |
| Astellas Pharma US IncMyrbetriq | $48 | $13,15419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Manning
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.